|
InvivoGen
nf κb ap 1 activation ![]() Nf κb Ap 1 Activation, supplied by InvivoGen, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+htlr2/Anti-hTLR2-IgA/pmc13196059-117-6-32 Average 95 stars, based on 1 article reviews
nf κb ap 1 activation - by Bioz Stars,
2026-09
95/100 stars
|
Buy from Supplier |
|
InvivoGen
tlr2 neutralizing antibody ![]() Tlr2 Neutralizing Antibody, supplied by InvivoGen, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+htlr2/Anti-hTLR2-IgA/pmc12925586-79-18-21 Average 95 stars, based on 1 article reviews
tlr2 neutralizing antibody - by Bioz Stars,
2026-09
95/100 stars
|
Buy from Supplier |
|
InvivoGen
tlr4 neutralizing antibody ![]() Tlr4 Neutralizing Antibody, supplied by InvivoGen, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+htlr2/Anti-hTLR2-IgA/pmc12925586-79-13-16 Average 95 stars, based on 1 article reviews
tlr4 neutralizing antibody - by Bioz Stars,
2026-09
95/100 stars
|
Buy from Supplier |
|
InvivoGen
anti htlr2 iga2 ![]() Anti Htlr2 Iga2, supplied by InvivoGen, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+htlr2/Anti-hTLR2-IgA/pmc12331918-198-7-10 Average 95 stars, based on 1 article reviews
anti htlr2 iga2 - by Bioz Stars,
2026-09
95/100 stars
|
Buy from Supplier |
|
InvivoGen
secretory iga ![]() Secretory Iga, supplied by InvivoGen, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+htlr2/Anti-hTLR2-IgA/bio_rxiv__2025__07__25__665838-174-0-8 Average 95 stars, based on 1 article reviews
secretory iga - by Bioz Stars,
2026-09
95/100 stars
|
Buy from Supplier |
|
InvivoGen
anti human tlr2 mab anti tlr2 ![]() Anti Human Tlr2 Mab Anti Tlr2, supplied by InvivoGen, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+htlr2/Anti-hTLR2-IgA/10__1007_slash_s13206___025___00226___x-336-8-12 Average 95 stars, based on 1 article reviews
anti human tlr2 mab anti tlr2 - by Bioz Stars,
2026-09
95/100 stars
|
Buy from Supplier |
|
InvivoGen
iga ![]() Iga, supplied by InvivoGen, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+htlr2/Anti-hTLR2-IgA/bio_rxiv__2025__07__01__662496-226-18-32 Average 95 stars, based on 1 article reviews
iga - by Bioz Stars,
2026-09
95/100 stars
|
Buy from Supplier |
|
InvivoGen
anti htlr2 iga ![]() Anti Htlr2 Iga, supplied by InvivoGen, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+htlr2/Anti-hTLR2-IgA/pm39843080-43-21-34 Average 95 stars, based on 1 article reviews
anti htlr2 iga - by Bioz Stars,
2026-09
95/100 stars
|
Buy from Supplier |
|
InvivoGen
escherichia coli ![]() Escherichia Coli, supplied by InvivoGen, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+htlr2/Anti-hTLR2-IgA/pm39843080-43-17-34 Average 95 stars, based on 1 article reviews
escherichia coli - by Bioz Stars,
2026-09
95/100 stars
|
Buy from Supplier |
Journal: Cell Communication and Signaling : CCS
Article Title: Extracellular vesicles derived from Enterococcus faecalis : inflammatory activation does not require internalization
doi: 10.1186/s12964-026-02926-9
Figure Lengend Snippet: Ef -EVs activate the NF-κB/AP-1 pathways in human reporter macrophages via TLR2 signaling. A dTHP1-XBlue cells were treated with Ef -EVs (100 − 50,000 EVs/cell). LPS (100 ng/mL) was used as a positive control. B dTHP1-XBlue cells were treated with EVs derived from clinical E. faecalis bloodstream isolates (1000-10,000 EVs/cell). LPS (100 ng/mL) and Pam 3 CSK 4 (100 ng/mL) were used as positive controls. C-E) dTHP1-XBlue cells were pretreated with increasing concentrations (from 0.1 to 5 µg/mL) of anti-hTLR2-IgA mAb (dark pink) or human IgA2 control mAb (light pink) for 1 h. Subsequently, cells were treated with either (C) EVs (7000 EVs/cell), (D) Pam 3 CSK 4 (TLR2 ligand, 1 ng/mL), or (E) LPS (TLR4 ligand, 1 ng/mL) in the presence of antibodies for 24 h. Cells treated with cell culture medium supplemented only with Ef -EVs (7000 EVs/cell) in (C, blue), Pam 3 CSK 4 (1 ng/mL) in (D, dark blue), or LPS (1 ng/mL) in (E, red) were used as positive activating controls while cells treated with cell culture medium supplemented alone ( C - E , light green) were used as negative controls. NF-κB/AP-1 activation was measured as the activity of secreted SEAP and expressed as a normalized value relative to the positive controls. Data are shown as means ± SD of three independent experiments ( N = 3, n ≥ 3) and analyzed either by Kruskal-Wallis test followed by Dunn’s multiple comparison post hoc test in (A and B) or by two-way analysis of variance (ANOVA) followed by Šídák multiple comparison post hoc test in ( C - E )
Article Snippet: To elucidate whether Ef -EVs induce
Techniques: Positive Control, Derivative Assay, Control, Cell Culture, Activation Assay, Activity Assay, Comparison
Journal: Cell Communication and Signaling : CCS
Article Title: Extracellular vesicles derived from Enterococcus faecalis : inflammatory activation does not require internalization
doi: 10.1186/s12964-026-02926-9
Figure Lengend Snippet: TLR2 controls EV-induced immune activation but does not function as an endocytic receptor for EV uptake. dTHP1-XBlue cells were pretreated with anti-hTLR2-IgA mAb (1 µg/mL) or human IgA2 control mAb (1 µg/mL) for 1 h. Cells were then treated with DiI-labeled Ef -EVs (7000 EVs/cell) in the presence of antibodies for 4 and 24 h. Cells incubated in cell culture medium alone were used as negative controls. Cells treated with cell culture medium supplemented with DiI-labeled Ef -EVs (7000 EVs/cell) were used as positive activating controls. For EV internalization assays, mean fluorescence intensity (B and C, upper panel) and EV-positive cells (B and C, lower panel) were quantified after 4 ( A and B ) and 24 h ( A and C ) of EV treatment by measuring fluorescence intensity associated with DiI-labeled Ef -EVs on the PE channel. NF-κB/AP-1 activation in D was measured after 24 h of EV incubation as the activity of secreted SEAP and expressed normalized to the positive controls. Quantitative results are presented as mean ± SD ( N = 3, n = 3) and were analyzed by Kruskal-Wallis test followed by Dunn’s multiple comparison post hoc test
Article Snippet: To elucidate whether Ef -EVs induce
Techniques: Activation Assay, Control, Labeling, Incubation, Cell Culture, Fluorescence, Activity Assay, Comparison
Journal: Cell Communication and Signaling : CCS
Article Title: Extracellular vesicles derived from Enterococcus faecalis : inflammatory activation does not require internalization
doi: 10.1186/s12964-026-02926-9
Figure Lengend Snippet: TLR2 engagement by Pam 3 CSK 4 -SUVs triggers inflammatory activation but does not enhance SUV internalization. A - C ) dTHP1-XBlue cells were treated with Pam 3 CSK 4 -SUVs (6 µM) containing increasing amounts of Pam 3 CSK 4 (from 0 to 0.4 mol% total SUV lipid composition) for 18 h. Cells incubated in cell culture medium alone were used as negative controls. Cells treated with cell culture medium containing Pam 3 CSK 4 -SUVs (6 µM, Pam 3 CSK 4 composition = 0.4 mol% total SUV lipid composition) were used as positive activating controls. D - F ) dTHP1-XBlue cells were pretreated with anti-hTLR2-IgA mAb (1 µg/mL) or human IgA2 control mAb (1 µg/mL) for 1 h. Cells were then treated with Pam 3 CSK 4 -SUVs (6 µM, Pam 3 CSK 4 composition = 0.04 mol% total SUV lipid composition) in the presence of antibodies for 18 h. Cells treated with cell culture medium containing Pam 3 CSK 4 -SUVs (6 µM, Pam 3 CSK 4 composition = 0.04 mol% total SUV lipid composition) were used as positive activating controls. For both experiments, cells incubated in cell culture medium alone were used as negative controls. Mean fluorescence intensity (B and E, upper panel) and SUV-positive cells (B and E, lower panel) were quantified after 18 h of treatment by measuring fluorescence intensity associated with SUVs on the APC channel. In C and F, NF-κB/AP-1 activation was measured after 18 h of SUV treatment as the activity of secreted SEAP and expressed normalized to the positive controls. Quantitative results are shown as mean ± SD ( N = 3, n = 3) and were analyzed by Kruskal-Wallis test followed by Dunn’s multiple comparison post hoc test
Article Snippet: To elucidate whether Ef -EVs induce
Techniques: Activation Assay, Incubation, Cell Culture, Control, Fluorescence, Activity Assay, Comparison
Journal: Cell Communication and Signaling : CCS
Article Title: Extracellular vesicles derived from Enterococcus faecalis : inflammatory activation does not require internalization
doi: 10.1186/s12964-026-02926-9
Figure Lengend Snippet: Routes of Ef -EV uptake. A and B ) dTHP1-XBlue cells were pretreated with pharmacological endocytosis inhibitors for 30 min. Afterward, cells were incubated with DiI-labeled Ef -EVs (7000 EVs/cell) in the presence of inhibitors for 4 h. Mean fluorescence intensity (B, upper panel) and EV-positive cells (B, lower panel) were quantified by measuring fluorescence intensity associated with DiI-labeled Ef -EVs on the PE channel. Cells treated by EVs dispersed in cell culture medium or medium containing DMSO (1% v/v) were used as positive uptake controls. C ) dTHP1-XBlue cells were pretreated with dynasore at 100 µM for 30 min. Afterward, cells were incubated with Ef -EVs (7000 EVs/cell) in the presence of dynasore at 100 µM for 24 h. Cells treated with cell culture medium supplemented only with Ef -EVs (7000 EVs/cell) were used as positive activating controls. NF-κB/AP-1 activation was measured as the activity of secreted SEAP and expressed as a normalized value relative to the positive control. Quantitative results are presented as mean ± SD of three independent experiments ( N = 3, n ≥ 3) and were analyzed by Kruskal-Wallis test followed by Dunn’s multiple comparison post hoc test
Article Snippet: To elucidate whether Ef -EVs induce
Techniques: Incubation, Labeling, Fluorescence, Cell Culture, Activation Assay, Activity Assay, Positive Control, Comparison
Journal: Neoplasia (New York, N.Y.)
Article Title: Microbe-associated molecular patterns differentially mediate carcinogenic alterations of the breast tissue in the context of obesity
doi: 10.1016/j.neo.2026.101284
Figure Lengend Snippet: LPS and flagellin induce DNA double-strand breaks in breast acini in a TLR-dependent manner. A. Representative comet images from neutral comet assays performed on 3D cultures of breast acini treated with vehicle (control), 1 μg/ml LPS, 1 μg/ml LTA, and 10 ng/ml flagellin for 72 h. Bleomycin (BLM; 20 mU/ml; 2h) was used as positive control. B. Comet assay quantification. n=300 acini from 3 biological replicates. C. Representative images for immunofluorescence staining of 53BP1 (red) in acini treated with MAMPs ± TLR inhibitors. Nuclei are counterstained with DAPI (blue). D-F. Quantification of 53BP1 foci numbers in acini treated with LPS ± TLR4 inhibitor (D), with LTA ± TLR2 inhibitor (E) or with flagellin ± TLR5 inhibitor (F). ns is not significant. *P<0.05, **P<0.01, ***P<0.001.
Article Snippet: For TLR blockade, cells were pre-treated for 1 h with 5 μg/ml of TLR4 neutralizing antibody (InvivoGen; mabg-htlr4),
Techniques: Control, Positive Control, Single Cell Gel Electrophoresis, Immunofluorescence, Staining
Journal: Neoplasia (New York, N.Y.)
Article Title: Microbe-associated molecular patterns differentially mediate carcinogenic alterations of the breast tissue in the context of obesity
doi: 10.1016/j.neo.2026.101284
Figure Lengend Snippet: Blockade of TLR4 and TLR5 mitigates DNA damage in the mammary glands. A. Schematic of the experiment. B-D-F. Representative images for TLR2 (B), TLR4 (D), and TLR5 (F) IHC signals in mammary glands of mice treated with saline, mismatch morpholino (MM) and the corresponding TLR morpholino (TLR M). Hematoxylin was used as a counterstain. Image analysis and quantification of TLR2/4/5-DAB positive areas is shown in the graphs (C,E,G). H. Representative comet images of the neutral comet assay performed on mammary cells treated with vehicle, MM, and TLR morpholinos. I. Quantification of comet assay results for the aforementioned mice groups. ns is not significant. *P<0.05, **P<0.01.
Article Snippet: For TLR blockade, cells were pre-treated for 1 h with 5 μg/ml of TLR4 neutralizing antibody (InvivoGen; mabg-htlr4),
Techniques: Saline, Neutral Comet Assay, Single Cell Gel Electrophoresis
Journal: Neoplasia (New York, N.Y.)
Article Title: Microbe-associated molecular patterns differentially mediate carcinogenic alterations of the breast tissue in the context of obesity
doi: 10.1016/j.neo.2026.101284
Figure Lengend Snippet: LPS and flagellin induce DNA double-strand breaks in breast acini in a TLR-dependent manner. A. Representative comet images from neutral comet assays performed on 3D cultures of breast acini treated with vehicle (control), 1 μg/ml LPS, 1 μg/ml LTA, and 10 ng/ml flagellin for 72 h. Bleomycin (BLM; 20 mU/ml; 2h) was used as positive control. B. Comet assay quantification. n=300 acini from 3 biological replicates. C. Representative images for immunofluorescence staining of 53BP1 (red) in acini treated with MAMPs ± TLR inhibitors. Nuclei are counterstained with DAPI (blue). D-F. Quantification of 53BP1 foci numbers in acini treated with LPS ± TLR4 inhibitor (D), with LTA ± TLR2 inhibitor (E) or with flagellin ± TLR5 inhibitor (F). ns is not significant. *P<0.05, **P<0.01, ***P<0.001.
Article Snippet: For TLR blockade, cells were pre-treated for 1 h with 5 μg/ml of
Techniques: Control, Positive Control, Single Cell Gel Electrophoresis, Immunofluorescence, Staining
Journal: Neoplasia (New York, N.Y.)
Article Title: Microbe-associated molecular patterns differentially mediate carcinogenic alterations of the breast tissue in the context of obesity
doi: 10.1016/j.neo.2026.101284
Figure Lengend Snippet: Blockade of TLR4 and TLR5 mitigates DNA damage in the mammary glands. A. Schematic of the experiment. B-D-F. Representative images for TLR2 (B), TLR4 (D), and TLR5 (F) IHC signals in mammary glands of mice treated with saline, mismatch morpholino (MM) and the corresponding TLR morpholino (TLR M). Hematoxylin was used as a counterstain. Image analysis and quantification of TLR2/4/5-DAB positive areas is shown in the graphs (C,E,G). H. Representative comet images of the neutral comet assay performed on mammary cells treated with vehicle, MM, and TLR morpholinos. I. Quantification of comet assay results for the aforementioned mice groups. ns is not significant. *P<0.05, **P<0.01.
Article Snippet: For TLR blockade, cells were pre-treated for 1 h with 5 μg/ml of
Techniques: Saline, Neutral Comet Assay, Single Cell Gel Electrophoresis